From MedscapeCME Clinical Briefs
Management of Acute Poisoning From Medication Ingestion Reviewed CME/CE
News Author: Laurie Barclay, MD
CME Author: Penny Murata, MD
CME/CE Released: 02/08/2010
February 8, 2010 — Family physicians should be familiar with treatment of accidental and intentional medication ingestions, according to a review of the management of acute poisoning caused by medication ingestion published in the February 1 issue of American Family Physician.
"Poisoning from medications can happen for a variety of reasons, including intentional overdose, inadvertently taking an extra dose, dispensing or measuring errors, and exposure through breast milk," write Ivar L. Frithsen, MD, and William M. Simpson, Jr, MD, from Medical University of South Carolina in Charleston.
"The most common medication poisonings in adults (in order of prevalence) include analgesics; sedatives, hypnotics, and antipsychotics; antidepressants; cardiovascular drugs; anticonvulsants; antihistamines; hormones and hormone antagonists; antimicrobials; stimulants and illicit drugs; cough and cold preparations; muscle relaxants; topical preparations; gastrointestinal preparations; and miscellaneous drugs," Drs. Frithsen and Simpson write. "The most common medication poisonings in children (in order of prevalence) include analgesics; topical preparations; cough and cold preparations; vitamins; antihistamines; gastrointestinal preparations; antimicrobials; hormones and hormone antagonists; electrolytes and minerals; cardiovascular drugs; dietary supplements, herbal medications, and homeopathic medications; asthma therapies; antidepressants; and sedatives, hypnotics, and antipsychotics."
In the United States, several million episodes of poisoning are reported each year, causing significant morbidity and mortality rates. Nearly one half of all poisonings reported in the United States are attributed to acute medication poisonings, which should be considered in patients with an acute change in mental status.
Steps in Treatment of Poisoning
The first steps in treatment of a patient who has been poisoned are to evaluate the airway, breathing, and circulation, and to perform a complete history. Poisoning with drugs from certain classes, notably anticholinergics, cholinergics, opioids, and sympathomimetics, are associated with constellations of symptoms known as toxidromes. For example, anticholinergic poisoning is associated with delirium; hyperthermia; ileus; mydriasis; tachycardia; urinary retention; and warm and dry skin.
For identification of electrolyte imbalances and/or impairment of liver and renal function, basic laboratory studies, such as a complete metabolic profile, are an important part of the workup for possible medication poisonings. Clinical presentation and history should help determine what other laboratory studies are indicated.
Unless a specific antidote is available, management is supportive in most cases, because less than 1% of poisonings are fatal. Although single-dose activated charcoal is the preferred modality of gastrointestinal tract decontamination, it should not be used in all patients. The review includes specific therapies for acute medication poisoning based on the type of drug ingested.
For unstable patients who have ingested toxic medications, ongoing treatment should aim to correct hypoxia and acidosis and to maintain adequate circulation. Even when these patients appear to be compensating, their mental or hemodynamic status may deteriorate rapidly. Children are particularly susceptible to profound effects from even small amounts of medication.
Multiple factors, including pharmacokinetics of the ingested substance and the ability to be monitored in the home environment, must be considered in the disposition of a person who has been poisoned. Longer monitoring is required for patients with signs or symptoms of toxicity. For patients who have attempted suicide, psychiatric evaluation and often psychiatric hospitalization are indicated. Counseling referral is recommended for patients with evidence of substance abuse.
Specific key clinical recommendations for practice, and their accompanying level of evidence rating, are as follows:
For most medication ingestions, single-dose activated charcoal is the modality of choice for gastrointestinal decontamination. This treatment can generally be used up to 1 hour after ingestion of a potentially toxic amount of medication (level of evidence, C).
There is no indication for using ipecac syrup in a healthcare setting (level of evidence, C).
"For unstable patients, admission to an intensive care unit is appropriate, and transfer to a tertiary care facility should be considered, especially with children," the review authors conclude. "For stable patients, the amount of observation time is based on the half-life of a medication, the amount ingested, and the formulation. Any patient who develops signs or symptoms of toxicity that do not reverse during the observation period should be admitted for further observation."
The review authors have disclosed no relevant financial relationships.
Am Fam Physician. 2010;81:316-323. Abstract
emedicineHealth provides clinicians with further information about drug overdose.
According to the American Association of Poison Control Centers' report by Bronstein and colleagues in the December 2007 issue of Clinical Toxicology, more than 2.4 million poisoning exposures were reported in the United States in 2006. Almost half of poisoning exposures were from prescription and over-the-counter medications.
This summary addresses the management of acute poisoning from medication ingestion.
The poison control center can assist with management on the telephone, at the office, or in the hospital.
Mortality rate is less than 1% from acute poisoning.
In patients with acute change in mental status, medication poisoning should be suspected based on acute behavioral changes, concern of others, and evidence of ingestion.
Initial approach includes assessment of airway, breathing, circulation; thorough history; and inspection for transdermal patches.
Important information includes time, identification, and amount of medication.
The gastrointestinal decontamination method of choice in most cases is activated charcoal within 1 hour of ingestion except in cases of decreased level of consciousness, low affinity of ingested medication for binding charcoal, and increased risk of gastrointestinal bleeding or perforation.
Other methods of gastrointestinal decontamination (in order of most to least used) are gastric lavage, cathartics, and whole-bowel irrigation.
Ipecac syrup has no role in the healthcare or home setting.
Basic symptom management includes Trendelenburg position and fluid resuscitation for hypotension, stimulation for apnea or lethargy, warming measures for hypothermia, and cooling measures for hyperthermia.
Complete metabolic profile can assess electrolytes and liver and renal function.
General toxicology screen is not helpful in immediate treatment.
Quantitative drug levels should be ordered based on history and signs and symptoms of ingestion of acetaminophen, carbamazepine, digoxin, ethanol, iron, lithium, phenobarbital, phenytoin, salicylates, theophylline, and valproate.
Serum N-acetyl-para-aminophenol levels should be checked in all unknown ingestions.
Arterial or venous blood gas analysis can identify acidosis and hypoxia.
Electrocardiography can assess arrhythmias.
Chest radiography can assess pulmonary edema.
Medications associated with certain signs and symptoms are acetaminophen, benzodiazepines, beta-blockers, calcium channel antagonists, clonidine, opioids, salicylates, sulfonylureas, and tricyclic antidepressants.
Specific medications have toxidromes or certain types of symptoms:
Anticholinergic symptoms: delirium, hyperthermia, ileus, tachycardia, urinary retention, warm and dry skin
Cholinergic, muscarinic symptoms: bradycardia, bronchorrhea, meiosis, wheezing
Cholinergic, nicotinic symptoms: abdominal pain, fasciculations, hypertension, paresis, tachycardia
Opioid symptoms: hypotension, hypothermia, hypoventilation, meiosis, sedation
Sympathomimetic symptoms: agitation, diaphoresis, hypertension, hyperthermia, mydriasis, psychosis, seizures, tachycardia
Certain medications have specific therapies:
Benzodiazepines: flumazenil unless contraindicated
Beta-blockers: glucagon, calcium gluconate, epinephrine, insulin plus dextrose, sodium bicarbonate
Calcium channel antagonists: glucagon, calcium gluconate, epinephrine, insulin euglycemia therapy, or sodium bicarbonate
Clonidine: naloxone, atropine, dopamine
Salicylates: urine alkalinization, possible hemodialysis
Sulfonylureas: dextrose, octreotide, glucagon
Tricyclic antidepressants: benzodiazepines, sodium bicarbonate, and dopamine or norepinephrine
Children have different treatment doses and are affected by smaller ingestions.
Disposition to intensive care unit, tertiary care facility, home, or psychiatric care depends on patient's stability, medication half-life, amount ingested, formulation, persistent signs and symptoms, home situation, suicidal attempt, and substance abuse.
The initial evaluation of acute medication poisoning includes assessment of airway, breathing, and circulation; thorough history; and determination of the presence of transdermal patches.
In most cases of medication poisoning, the gastrointestinal decontamination modality of choice is single-dose activated charcoal, which can be given up to 1 hour after ingestion. Ipecac syrup use is not indicated.
Questions answered incorrectly will be highlighted.
In a patient who is suspected of ingesting a toxic amount of medication, assessment of which of the following is most likely to be useful in the initial evaluation of acute poisoning?
All of the above
A 40-year-old patient presenting in the emergency department for medication poisoning needs gastrointestinal decontamination. Which of the following forms is most likely to be recommended?
All of the above